BioStock: Alligator granted US patent for cancer therapy platform

Through its propriatary Neo-X-Prime platform, Alligator Bioscience has generated ATOR-4066 – a bispecific antibody aimed at boosting immune cells in cancer patients. Now, the company has been granted the first US patent protecting ATOR-4066. BioStock spoke with Alligator’s CEO Søren Bregenholt to better understand the importance of this patent.

Read the interview with Søren Bregenholt at biostock.se:

Alligator granted US patent for cancer therapy platform - BioStock

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/